Abstract
Background Long Covid (LC) is a clinical syndrome of persistent, fluctuating symptoms subsequent to COVID-19 infection with a prevalence global estimate of many millions of cases. LC has significant detrimental effects on health-related quality of life (HRQoL), activities of daily living (ADL), and work productivity. Condition-specific patient-reported outcome measures (PROMs), such as the modified Covid-19 Yorkshire Rehabilitation Scale (C19-YRSm), have been developed to capture the impact of LC. However, these do not provide health utility data required for cost-utility analyses of LC interventions. The aim of this study was therefore to derive a mapping algorithm for the C19-YRSm to enable health utilities to be generated from this PROM.
Methods Data were collected from a large study evaluating LC services in the UK. A total of 1434 people with LC had completed both the C19-YRSm and the EQ-5D-5L on the same day. The EQ-5D-5L responses were then converted to EQ-5D-3L utility scores. Correlation and linear regression analyses were applied to determine items from the C19-YRSm and covariates for inclusion in the algorithm. Model fit, mean differences across the range of EQ-5D-3L scores (−0.59 to 1), and Bland-Altman plots were used to evaluate the algorithm. Responsiveness (standardised response mean; SRM) of the mapped utilities was also investigated on a subset of participants with repeat assessments (N=85).
Results There was a strong level of association between 8 items and 2 domains on the C19-YRSm with the EQ-5D single-item dimensions. These related to joint pain, muscle pain, anxiety, depression, walking/moving around, personal care, ADL, and social role, as well as Overall Health and Other Symptoms. Model fit was good (R2 = 0.7). The mean difference between the actual and mapped scores was < 0.10 for the range from 0 to 1 indicating a good degree of targeting for positive values of the EQ-5D-3L. The SRM for the mapped EQ-5D-3L health utilities (based on the C19-YRSm) was 0.37 compared to 0.17 for the observed EQ-5D-3L utility scores, suggesting the mapped EQ-5D-3L is more responsive to change.
Conclusions We have developed a simple, responsive, and robust mapping algorithm to enable EQ-5D-3L health utilities to be generated from 10 items of the C19-YRSm. This mapping algorithm will facilitate economic evaluations of interventions, treatment, and management of people with LC, as well as further helping to describe and characterise patients with LC irrespective of any treatment and interventions.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work is independent research funded by the National Institute for Health and Care Research (NIHR) grant Ref COV-LT2-0016.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics approval for the LOCOMOTION study was obtained from the Bradford and Leeds Research Ethics Committee on behalf of Health Research Authority and Health and Care Research Wales (reference: 21/YH/0276).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
The LOCOMOTION Consortium has been addded to the author list.
Data Availability
All data produced in the present work are contained in the manuscript.
List of abbreviations
- AIC
- Akaike Information Criteria
- C19-YRSm
- Covid 19 Yorkshire Rehabilitation Screening Tool (modified)
- CI
- Confidence Interval
- EQ-5D-3L
- EuroQol 5-Dimension 3-Level
- EQ-5D-5L
- EuroQol 5-Dimension 5-Level
- FD
- Functional Disability (from the C19-YRSm)
- HRQoL
- Health-related Quality of Life
- HTA
- Health Technology Assessment
- LC
- Long COVID
- MAPS
- MApping onto Preference-based measures reporting Standards
- NHS
- National Health Service
- NICE
- National Institute for Health and Care Excellence
- OH
- Overall Health (from the C19-YRSm)
- OLS
- Ordinary Least Squares
- OS
- Other Symptoms (from the C19-YRSm)
- PCS
- Post-COVID Syndrome
- PROM
- Patient-reported Outcome Measure
- RMSE
- Root Mean Squared Error
- SD
- Standard Deviation
- SE
- Standard Error
- SRM
- Standardised Response Mean
- SS
- Symptom Severity (from the C19-YRSm)
- VAS
- Visual Analogue Scale